Table 3.
Prognostic echo findings in COVID-19—parameters associated with increased mortality.
| RV systolic function | PHTN | LV systolic function | LV diastolic function | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | RV size | RVEF | TAPSE | FAC | S′ | AT | Tei index | Longitudinal strain | LV size | LVEF | Longitudinal strain | ||
| Mahmoud-Elsayed et al. (19) | |||||||||||||
| Moody et al. (20) | – | + | + | ||||||||||
| Szekely et al. (33) | + | + | + | + | |||||||||
| Rothschild et al. (21) | + | + | |||||||||||
| Argulian et al. (34) | + | ||||||||||||
| Kim et al. (35) | + | + | + | ||||||||||
| Baycan et al. (13) | + | + | |||||||||||
| Li et al. (36) | + | + | + | + | |||||||||
| Pagnesi et al. (40) | + | ||||||||||||
COVID-19, coronavirus disease 2019; RV, right ventricle; PHTN, pulmonary hypertension; LV, left ventricle; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular plane peak systolic excursion; FAC, fractional area change; AT, acceleration time.